SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-293389
Filing Date
2023-12-12
Accepted
2023-12-12 16:12:31
Documents
18
Period of Report
2023-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d654575d8k.htm   iXBRL 8-K 51001
2 EX-2.1 d654575dex21.htm EX-2.1 627545
3 EX-99.1 d654575dex991.htm EX-99.1 58978
4 EX-99.2 d654575dex992.htm EX-99.2 17241
5 EX-99.3 d654575dex993.htm EX-99.3 15207
9 GRAPHIC g654575g1212125312137.jpg GRAPHIC 3857
10 GRAPHIC g654575g1212130423263.jpg GRAPHIC 3857
  Complete submission text file 0001193125-23-293389.txt   1107229

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA icvx-20231211.xsd EX-101.SCH 2842
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE icvx-20231211_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icvx-20231211_pre.xml EX-101.PRE 11702
12 EXTRACTED XBRL INSTANCE DOCUMENT d654575d8k_htm.xml XML 3458
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 231481372
SIC: 2836 Biological Products, (No Diagnostic Substances)